Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062296
Status:
COMPLETED
Last Update Posted:
2013-07-11
First Post:
2003-06-05
Brief Title:
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Fox Chase Cancer Center